Cervical Dystonia Market Research Report Forecast to 2030

Cervical Dystonia Market Share, Growth and Trends analysis By Type (Torticollis, Retrocollis, Laterocollis and others), Treatment (Oral Therapy, Intravenous, Surgery and other), End User (Hospital, Clinics and other) - Forecast till 2030

ID: MRFR/Pharma/0907-HCR | January 2023 | Region: Global | 85 Pages         

Cervical dystonia Market Speak to Analyst Request a Free Sample

Cervical Dystonia Market Overview


The Cervical Dystonia Market is anticipated to reach USD 384.6 Million by 2030 at 7.3% CAGR during the forecast period 2022-2030. Cervical dystonia was recognized as the primary cause of dystonia, impacting over 80% of persons with the illness and necessitating an effective therapy, propelling the worldwide Market Outlook forward. Cervical dystonia, commonly known as spasmodic torticollis, is a rare disorder. It is a painful chronic neurological movement disease in which the neck turns involuntarily in any direction.


It's a rare illness. Cervical dystonia causes the head to tilt backward or forward uncontrollably. The illness can strike anyone at any age, but it is most common in middle-aged persons, and it can sometimes go away without treatment. Cervical dystonia can be inherited and caused by a neurological condition, or it can be brought on by physical trauma. Cervical dystonia is inherited in tandem with early-onset generalized dystonia linked to the DYT1 gene. Cervical dystonia Market Analysis shows that the market is expected to grow significantly during the Forecast period.


COVID-19 Analysis


COVID-19 is an infectious disease that first appeared in late December in China's Hubei province, in the city of Wuhan. The virus that causes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is highly infectious and spreads from person to person. The disease has expanded to about 213 nations around the world since the outbreak in December 2019, prompting the World Health Organization to declare it a public health emergency. Pharmaceutical and biotech businesses, in collaboration with governments around the world, are working to combat the COVID-19 outbreak, from vaccine development to pharmaceutical supply chain planning. Furthermore, routinely used medications like hydroxychloroquine have shown a huge increase in demand for COVID-19 treatment. Due to the enormous demand for these treatments, manufacturers of COVID-19 management drugs have a lot of prospects, as many wealthy countries are running out of them. As a result of the demand for COVID-19 vaccines and treatment medications, the pharmaceutical and biotechnology sectors are predicted to increase significantly in the future. This, in turn, is projected to have a major impact on the global Cervical dystonia Market Value.


Cervical Dystonia Market Dynamics


Drivers


The growing aging population around the world is one of the primary driving reasons for the Cervical dystonia Market Size. Cervical dystonia is more likely to affect women than it is to impact men. In addition, the growing number of cervical dystonia treatments and infrastructure improvements have fueled the Cervical dystonia Market Growth. Lower back pain is the largest cause of impairment worldwide, with musculoskeletal diseases being the leading cause of disability. Cervical dystonia impedes mobility and dexterity, resulting in early retirement from a job, diminished wealth, and diminished capacity to participate in social duties. Cervical dystonia were the top contributors to worldwide disability (accounting for 16 percent of all years lived with impairment), according to a 2017 study by the World Health Organization (WHO), and lower back pain was the single largest cause of disability. The prevalence of Cervical dystonia varies depending on age and diagnosis. Around the world, 20% to 33% of people suffer from painful Cervical dystonia leading to increased Cervical dystonia Market Trends.


Restraints


On the other side, the low treatment success rate and rising treatment costs are the main factors limiting the Cervical dystonia Market Value.


The number of persons over the age of 60 is predicted to double throughout the projection period, according to the United Nations. The dystonia population is rapidly growing over the world and thus restrains the Market Outlook. The present dystonia population is approximately 13% of the global population, and it is growing at a rate of 3% every year. At the moment, Europe has a sizable dystonia population.


Cervical dystonia market Analysis for each country, including growth in healthcare capital expenditure, installed base of various types of products for the Market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios, as well as their impact on the Market Trends.


Study Objectives


The study provides a complete analysis of the market structure, as well as forecasts for the major segments and sub-segments of the market for the next eight years, as well as detailed information on the factors influencing the global Market Share.


The research provides a detailed overview of the global cervical dystonia market, including all potential market segmentation. Also included is a detailed analysis of emerging main players in the industry, as well as their effective tactics and the factors that impact the market.


The report also tracks and analyzes competitive trends of the market, such as joint ventures, strategic alliances, mergers and acquisitions, new product launches, and research & development. The cervical dystonia market is broken down into segments and sub-segments, with detailed information on each. Also included is a market analysis by region: North America, Europe, Asia Pacific, the Middle East, and Africa.


Cervical Dystonia Market Segment Overview


The Global segmented by type, treatment, end user:


Based on the Drug type, the market has been segmented as follows:



  • Torticollis

  • Retrocollis

  • Laterocollis

  • Others


Based on the treatment, the market has been segmented as follows:



  • Oral Therapy

  • Intravenous

  • Surgery

  • Others


Based on the end-user, the market has been segmented as follows:



  • Hospital

  • Clinics

  • Others


Cervical Dystonia Market Regional Classification


America



  • The U.S.

  • Canada

  • Brazil

  • Mexico


Europe



  • Germany

  • France

  • The U.K.

  • Italy

  • Spain

  • Rest of Europe


Asia Pacific



  • China

  • Japan

  • India

  • Australia

  • New Zealand

  • Rest of Asia Pacific


Middle East & Africa



  • GCC Countries

  • South Africa

  • Rest of the Middle East & Africa


North America is the market leader in the cervical dystonia market, followed by Europe. The rising prevalence of cervical dystonia, as well as the aging population, are driving the market in this region. The market is increasing at the quickest rate in the Asia Pacific. While the Middle East and Africa contribute the least to the market due to a lack of development in the pharmaceutical and medical sectors.


Cervical Dystonia Market Competitive Landscape


The major key players of the global cervical dystonia market are ALLERGAN (Ireland), Solstice Neurosciences LLC, Ipsen Biopharmaceuticals Inc. (France), Addex Therapeutics (Switzerland), Merz Inc (US), Revance Therapeutics Inc. (US), and many others. Financials, revenue generated, market potential, R&D investment, new market initiatives, global presence, company overview, manufacturing sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are just a few of the details included.


Recent Developments


Revance Therapeutics, Inc., a biotechnology company, announced positive results from its ASPEN-1 Phase 3 randomized, double-blind clinical trial for DaxibotulinumtoxinA for Injection, an investigational drug candidate for the treatment of cervical dystonia, a chronic and neurologic condition affecting the muscles of the neck.


Pfizer Inc. announced in 2020 that a Phase 3 research looked to examine the safety and efficacy of abrocitinib, an experimental oral once-daily Janus kinase 1 (JAK1) inhibitor, in people with moderate to severe cervical dystonia who were also on topical medication.


The United States Food and Drug Administration (FDA) approved the expanded use of Dysport (abobotulinumtoxinA) for the treatment of cervical dystonia in pediatric patients in July 2020, according to Ipsen Biopharmaceuticals.


Report Overview


The cervical dystonia market report includes thorough primary research as well as detailed qualitative and quantitative analysis by numerous industry professionals and key opinion leaders to acquire a better understanding of the market and industry performance. The report provides a detailed picture of the current market situation, including historical and forecast in terms of value and volume, technical advancements, macroeconomic considerations, and market controlling factors. The research analyses the top significant participants in the cervical dystonia business, as well as their strategies. The report provides a gist of the various market categories and geographies. The study also examines significant players, major collaborations, mergers, and acquisitions, as well as current innovation and corporate policies.



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 384.6 Million
  CAGR   7.3%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Treatment, End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   ALLERGAN (Ireland), Solstice Neurosciences LLC, Ipsen Biopharmaceuticals Inc. (France), Merz Inc (US), Addex Therapeutics (Switzerland) Revance Therapeutics Inc. (US) and many other
  Key Market Opportunities   New product launches and R&D Amongst major key Players
  Key Market Drivers

  • Increasing aging population across the globe
  • Increasing number of treatment for cervical Dystonia
  • Improvement in infrastructure


  • Speak to Analyst Ask for Customization